E Archimbaud

7.6k citations
124 papers · 5.1k · 1 hit paper · h-index 34

Impact in

  • Hematology top 0.1%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 1%

Papers in

  • Hematology 86
    • Acute Myeloid Leukemia Research 70
    • Hematopoietic Stem Cell Transplantation 21
    • Multiple Myeloma Research and Treatments 10
    • Chronic Myeloid Leukemia Treatments 9
  • Oncology 34
    • Neutropenia and Cancer Infections 20
Co-authors
D Fière (58 shared papers)Lydia Campos (18 shared papers)Xavier Thomas (34 shared papers)Denis Guyotat (23 shared papers)Pierre Fenaux (14 shared papers)Odile Sabido (4 shared papers)C. Vasselon (3 shared papers)N. Roubi (3 shared papers)
Journals
Blood (23 papers)Annals of Hematology (9 papers)British Journal of Haematology (7 papers)Leukemia Research (6 papers)Journal of Clinical Oncology (5 papers)
Partner nations
FranceUnited StatesBelgium

In The Last Decade

E Archimbaud

124 papers receiving 4.9k citations

E Archimbaud's Hit Papers

High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy 1993 · 643 citations
6430+11+22Years since publication200400600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

  • it has ≥500 total citations;
  • it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
  • it reaches the top citation threshold in at least one of its specific research topics.
  1. 1993 Blood

Peers

E Archimbaud
Comparison fields: 5 of 107
  • Hematology 3.1k
  • Genetics 527
  • Oncology 1.2k
  • Biochemistry 219
  • Public Health, Environmental and Occupational Health 918
Replace R Ohno with:
R Ohno Japan
Pau Montesinos Spain
Martin Höglund Sweden
Peter Westervelt United States
Pierre W. Wijermans Netherlands
Claude Gardin France
Bruno C. Medeiros United States
Lionel Adès France
David R. Head United States
Stéphane de Botton France
E Archimbaud relative to R Ohno Japan R Ohno's profile →
Citations per field
00.5×1.6×
R Ohno · 1×
Citations per year

Countries citing papers authored by E Archimbaud

Since Specialization
Citations

This map shows the geographic impact of E Archimbaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Archimbaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Archimbaud more than expected).

Fields of papers citing papers by E Archimbaud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Archimbaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Archimbaud. The network helps show where E Archimbaud may publish in the future.

Co-authors

The 25 scholars most cited alongside E Archimbaud, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E Archimbaud Line = papers co-authored together E Archimbaud links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 124 papers — load more, or switch the sort, to bring in the rest.

#Work
1
High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy
Blood ·Lydia Campos, JP Rouault, Odile Sabido, P. Oriol, N. Roubi, C. Vasselon, E Archimbaud, JP Magaud, D Guyotat
Hit paper breakdown →		1993643
2
Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis [see comments]
Blood ·Lydia Campos, Denis Guyotat, E Archimbaud, P Calmard-Oriol, T Tsuruo, Jacques Troncy, D. Treille, D Fière
1992426
3
Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group
Blood ·Pierre Fenaux, M. Le Deley, Sylvie Castaigné, E Archimbaud, Christine Chomienne, Hartmut Link, A. Guerci, M Duarte, MT Daniel, Deborah A. Bowen
1993375
4
Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.
Journal of Clinical Oncology ·Bob Löwenberg, Stefan Suciu, E Archimbaud, H. L. Haak, Pierre Stryckmans, Ralph Cataldo, A. W. Dekker, Zwi Berneman, A. Thyss, J. van der Lelie, Pieter Sonneveld, Giuseppe Visani, Georges Fillet, M. Hayat, A Hagemeijer, G. Solbu, R Zittoun
1998218
5
All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases
Blood ·Pierre Fenaux, Sylvie Castaigné, Hervé Dombret, E Archimbaud, M Duarte, Pierre Morel, Thierry Lamy, H Tilly, A. Guerci, F. Maloisel
1992178
6
Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse [see comments]
Blood ·Didier Blaise, D Maraninchi, E Archimbaud, J Reiffers, A Devergié, J.P. Jouet, Nöel Milpied, Michel Attal, Mauricette Michallet, Norbert Ifrah
1992174
7
Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer and the Dutch Belgian Hemato-Oncology Cooperative Group.
Blood ·Bob Löwenberg, Stefan Suciu, E Archimbaud, G.J. Ossenkoppele, G. Verhoef, Edo Vellenga, P. Wijermans, Zwi Berneman, A. W. Dekker, Pierre Stryckmans, Harry C. Schouten, U. Jehn, Petra Muus, Pieter Sonneveld, M Dardenne, R Zittoun
1997169
8
Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse [see comments]
Blood ·Didier Blaise, D Maraninchi, E Archimbaud, J Reiffers, A Devergié, J P Jouet, Nöel Milpied, Michel Attal, Mauricette Michallet, Norbert Ifrah
1992140
9
Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature.
Journal of Clinical Oncology ·Bruno Quesnel, H. Kantarjian, J P Bjergaard, P Brault, Elihu H. Estey, Jean Luc Laı̈, H Tilly, Anne Marie Stoppa, E Archimbaud, J L Harousseau
1993126
10
Surface marker expression in adult acute myeloid leukaemia: correlations with initial characteristics, morphology and response to therapy
British Journal of Haematology ·Lydia Campos, Denis Guyotat, E Archimbaud, Yves Devaux, D. Treille, A. Larèse, Jean Maupas, O Gentilhomme, A. Ehrsam, D Fière
1989118
11
Rearrangement of CCND1 (BCL1/PRAD1) 3' untranslated region in mantle- cell lymphomas and t(11q13)-associated leukemias
Blood ·Ruth Rimokh, F Berger, Christian Bastard, Benjamin Klein, Martine French, E Archimbaud, JP Rouault, B Santa Lucia, Laurent Duret, M Vuillaume
1994110
12
Post-transplant obstructive lung disease ("bronchiolitis obliterans"): a clinical comparative study of bone marrow and lung transplant patients
European Respiratory Journal ·F. Philit, T Wiesendanger, E Archimbaud, Jf Mornex, J Brune, J.-F. Cordier
199598
13
Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint
Leukemia ·E Archimbaud, C Charrin, J.P. Magaud, Lydia Campos, Xavier Thomas, D Fière, Ruth Rimokh
199893
14
Timed sequential chemotherapy for previously treated patients with acute myeloid leukemia: long-term follow-up of the etoposide, mitoxantrone, and cytarabine-86 trial.
Journal of Clinical Oncology ·E Archimbaud, Xavier Thomas, V. Leblond, M Michallet, Pierre Fenaux, Catherine Cordonnier, François Dreyfus, Xavier Troussard, J Jaubert, Philippe Travade
199585
15
Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma
Experimental Hematology ·Mauricette Michallet, Thierry Philip, Irène Philip, Hubert Godinot, Catherine Sebban, Gilles Salles, Anne Thiébaut, Pierre Biron, (unknown), Philippe Mazars, N. Roubi, Tom Leemhuis, Elie G. Hanania, Christopher L. Reading, Gilbert Fine, K Atkinson, Chris Juttner, Bertrand Coiffier, D Fière, E Archimbaud
200083
16
A Randomized, Double-Blind, Placebo-Controlled Study With Pegylated Recombinant Human Megakaryocyte Growth and Development Factor (PEG-rHuMGDF) as an Adjunct to Chemotherapy for Adults With De Novo Acute Myeloid Leukemia
Blood ·E Archimbaud, Oliver G. Ottmann, John A. Liu Yin, Klaus Lechner, Hervé Dombret, Miguel Á. Sanz, Gerhard Heil, Pierre Fenaux, Wolfram Brugger, Alan Barge, Caroline O’Brien-Ewen, James Matcham, Dieter Hoelzer
199983
17
A chromosome 12 coding region is juxtaposed to the MYC protooncogene locus in a t(8; 12)(q24;q22) translocation in a case of B‐cell chronic lymphocytic leukemia
Genes Chromosomes and Cancer ·Ruth Rimokh, Jean‐Pierre Rouault, Kamal Wahbi, Mylène Gadoux, Marina Lafage, E Archimbaud, C Charrin, O Gentilhomme, D Germain, Jacques Samarut, Jean‐Pierre Magaud
199180
18
Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemia
Blood ·Sylvie Castaigné, Philippe Lefèbvre, Christine Chomienne, Etienne Suc, Françoise Rigal‐Huguet, Claude Gardin, Alain Delmer, E Archimbaud, Hervé Tilly, Maud Janvier
199373
19
A randomized phase II study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: an EORTC Leukemia Cooperative Group phase II study (06893).
PubMed ·Roel Willemze, Stefan Suciu, E Archimbaud, Petra Muus, Pierre Stryckmans, E A Louwagie, Zwi Berneman, M T'Jean, P. Wijermans, H. Döhner, U. Jehn, Boris Labar, Branimir Jakšić, M Dardenne, R Zittoun
199772
20
Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis
Annals of Hematology ·Anne Thiébaut, Xavier Thomas, A Belhabri, Bruno Anglaret, E Archimbaud
200069

About E Archimbaud

E Archimbaud is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Public Health, Environmental and Occupational Health, having authored 124 papers that have together received 5.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (70 papers), Hematopoietic Stem Cell Transplantation (21 papers), Neutropenia and Cancer Infections (20 papers), Acute Lymphoblastic Leukemia research (18 papers), Chronic Lymphocytic Leukemia Research (17 papers), Retinoids in leukemia and cellular processes (16 papers), Multiple Myeloma Research and Treatments (10 papers) and Chronic Myeloid Leukemia Treatments (9 papers). The work is most often cited by research in Hematology (3.1k citations), Genetics (527 citations), Oncology (1.2k citations), Biochemistry (219 citations) and Public Health, Environmental and Occupational Health (918 citations). E Archimbaud has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include D Fière, Lydia Campos, Xavier Thomas, Denis Guyotat, Pierre Fenaux, Odile Sabido, C. Vasselon, N. Roubi, P. Oriol and JP Magaud. Their work appears in journals such as Blood, Annals of Hematology, British Journal of Haematology, Leukemia Research and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R OhnoBreakdown of academic impact, for papers by Pau MontesinosBreakdown of academic impact, for papers by Martin HöglundBreakdown of academic impact, for papers by Peter WesterveltBreakdown of academic impact, for papers by Pierre W. WijermansBreakdown of academic impact, for papers by Claude GardinBreakdown of academic impact, for papers by Bruno C. MedeirosBreakdown of academic impact, for papers by Lionel AdèsBreakdown of academic impact, for papers by David R. HeadBreakdown of academic impact, for papers by Stéphane de Botton